Multi-resistant pathogens are a serious and growing problem in modern medicine. Where antibiotics remain ineffective, these bacteria can cause life-threatening infections. Researchers at Empa and ETH Zurich have now developed novel nanoparticles that can be used to detect and kill multidrug-resistant pathogens hiding in body cells, as they write in a recent study in the journal Nanoscale.
Digital transformation is a hard and long endeavor, especially for companies with legacy technology stacks, processes or cultures. However, it is no longer a discretionary initiative. Digitization is a secular trend, and the expectations from customers and associates to engage digitally are becoming table stakes.